FIELD: medicine, pharmacy.
SUBSTANCE: invention proposes a system for controlled release of temosolomide that comprises 10 wt.-% of temosolomide and biodegradable polymeric material representing polyanhydride. This polyanhydride is synthesized by condensation of 3,4-bis-(p-carboxyphenoxy)propane with sebacic acid in their ratio = 20:80, respectively. The system for controlled release of temosolomide represents implanted tablets. Implants are able to release anticancer preparation temosolomide by the controlled manner in vivo for prolonged time from 1 h to 4 weeks.
EFFECT: improved and valuable medicinal and pharmaceutical properties of system.
13 cl, 1 tbl, 2 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR SUSTAINED-RELEASE OF HUMAN GROWTH HORMONE | 1996 |
|
RU2161502C2 |
| SUNITINIB-BASED COMPOSITIONS AND METHODS FOR USING THEM FOR TREATING EYE DISEASES | 2015 |
|
RU2729731C2 |
| COMPOSITION AND MICROSPHERE WITH CONTROLLED EXENDIN RELEASE AND METHOD OF OBTAINING MICROSPHERE | 2008 |
|
RU2463040C2 |
| COMPOSITION IN THE FORM OF MICROSPHERES FOR PROLONGED AND CONTROLLED RELEASE OF PEPTIDE MEDICINAL SUBSTANCE | 1992 |
|
RU2103994C1 |
| DELIVERED PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2005 |
|
RU2390355C2 |
| COATING FOR MEDICAL DEVICE CONTAINING ANTITHROMBOTIC CONJUGATE | 2008 |
|
RU2472529C2 |
| POLYMER PROTEIN MICROPARTICLES | 2012 |
|
RU2768492C2 |
| LONG-ACTING NALTREXONE MICROPARTICLE INJECTABLE COMPOSITIONS | 2019 |
|
RU2817016C2 |
| HEMIHYDRATE OF NALTREXONE BASE, METHOD FOR ITS OBTAINING AND METHOD FOR MICROSPHERES MANUFACTURING | 2012 |
|
RU2505542C1 |
| HIGH STABILITY PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2427383C2 |
